Show
Sort by
-
- Journal Article
- A2
- open access
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN
-
- Journal Article
- A1
- open access
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
-
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways
-
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib